Cellular interleukin enhancer-binding factor 2, ilf2, inhibits japanese encephalitis virus replication in vitro

10Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Japanese encephalitis virus (JEV) is a zoonotic mosquito-borne flavivirus which is the leading causative agent of viral encephalitis in endemic regions. JEV NS3 is a component of the viral replicase complex and is a multifunctional protein. In this study, interleukin enhancer-binding factor 2(ILF2)is identified as an ovel cellular protein interacting with NS3 through co-immuno precipitation assay and LC-MS/MS. The expression of ILF2 is decreased in JEV-infected human embryonic kidney (293T) cells. The knockdown of endogenous ILF2 by special short hairpin RNA (shRNA) positively regulates JEV propagation, whereas the overexpression of ILF2 results in a significantly reduced JEV genome synthesis. Further analysis revealed that the knockdown of ILF2 positively regulates viral replication by JEV replicon system studies. These results suggest that ILF2 may act as a potential antiviral agent against JEV infection.

Cite

CITATION STYLE

APA

Cui, X., Qian, P., Rao, T., Wei, Y., Zhao, F., Zhang, H., … Li, X. (2019). Cellular interleukin enhancer-binding factor 2, ilf2, inhibits japanese encephalitis virus replication in vitro. Viruses, 11(6). https://doi.org/10.3390/v11060559

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free